Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
中央真核代谢检查点激酶雷帕霉素 (MTOR) 调节嗜肺军团菌发病机制
基本信息
- 批准号:10329977
- 负责人:
- 金额:$ 36.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-11 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AgonistAlveolar MacrophagesAnabolismAutophagocytosisBacterial InfectionsBindingBinding ProteinsBiochemicalBiochemical GeneticsCatabolismCellsCytosolDefense MechanismsEtiologyEukaryotaEukaryotic CellEventEvolutionFRAP1 geneHomeostasisHost DefenseHumanIL6 geneImmuneImmune responseImmunityInfectionInflammationInflammatoryInflammatory ResponseInnate Immune SystemInterleukin-10Interleukin-12InterruptionInvadedKnowledgeLegionellaLegionella pneumophilaLegionnaires&apos DiseaseLinkLipidsLungMaintenanceMediatingMembraneMetabolicMetabolismMicrobeMolecularOrganellesParasitesPathogenesisPathogenicityPathway interactionsPhosphotransferasesProcessProtein-Serine-Threonine KinasesProteinsProteolysisProtozoaRegulationRegulatory ElementRuptureShapesSterolsSystemTNF geneTestingToxinTrainingUbiquitinVirulenceVirulentWorkantimicrobialatypical pneumoniabasecytokinedesigngenetic approachimaging approachimmune system functioninsightlipid biosynthesismacrophagemutantnovelpathogenpathogenic bacteriaprogramsreceptorrespiratoryrespiratory pathogenresponsesensortranscription factorubiquitin ligase
项目摘要
The work proposed here seeks to investigate the mechanism by which mammalian
macrophages suppress the metabolic checkpoint kinase Mechanistic target of rapamycin
(MTOR) to promote immune defenses and counteract anabolic reprogramming by the vacuolar
pathogen Legionella pneumophila. MTOR is a universally conserved master switch regulating
catabolism to anabolism transition in eukaryotic cells. Vacuolar pathogens rely on host
metabolites not only for bacterial replication but also for maintenance of their intracellular
niches. The human respiratory pathogen Legionella pneumophila is a prototypical vacuolar
pathogen that infects and replicates within mammalian macrophages. We uncovered that
Legionella stimulates host membrane biosynthesis to expand its niche by subverting MTOR.
However, a host suppression pathway counteracts L. pneumophila-induced MTOR activation by
targeting MTOR for ubiquitin-dependent proteolysis. In macrophages, MTOR suppression
promotes cell intrinsic (autophagy) and cell extrinsic (inflammation) host defenses. Specifically,
pathogenic L. pneumophila expressing the type IVb secretion system (T4bSS) but not the
avirulent mutants lacking a functional T4bSS elicited the host MTOR suppression response.
Thus, we hypothesize that in mammalian macrophages MTOR functions downstream of
homeostatic mechanisms that sense the pathogenic potential of invading microbes to potentiate
host defenses. Such mechanisms operate by detecting virulence adaptations encoded by
bacterial pathogens (such as specialized secretion systems and secreted toxins), which
frequently produce pathogen-specific signatures. In the first aim we will determine the
mechanism by which Legionella subverts MTOR function, when the host suppression pathway is
inactivated. In the second aim we are going to use biochemical and genetic approaches to
determine how the Legionella intracellular niche is controlled by host metabolic regulators. Our
third aim is to elucidate how the pathogen signature that elicits MTOR suppression is
generated. To this end, we will perform a systematic analysis of the Legionella intracellular niche
using a variety of imaging approaches to define the early events that trigger MTOR
suppression.
这里提出的工作旨在调查哺乳动物的机制
巨噬细胞抑制雷帕霉素的代谢检查点激酶机械靶标
(MTOR)促进免疫防御和抵消液泡的合成代谢重编程
病原体肺炎。 MTOR是一种普遍保守的主开关调节
对真核细胞中代谢过渡的分解代谢。液泡病原体依赖宿主
代谢物不仅用于细菌复制,而且还用于维持其细胞内
利基。人类呼吸道病原体肺炎是一种典型的液泡
在哺乳动物巨噬细胞中感染和复制的病原体。我们发现了这一点
军团菌刺激宿主膜的生物合成,通过颠覆MTOR来扩展其利基市场。
然而,宿主抑制途径抵消了肺炎乳杆菌诱导的mTOR激活
靶向MTOR用于泛素依赖性蛋白水解。在巨噬细胞中,mtor抑制
促进细胞固有(自噬)和细胞外部(炎症)宿主防御能力。具体来说,
表达IVB型分泌系统(T4BS)的致病性肺炎乳杆菌,但不是
缺乏功能性T4BS的无毒突变体引起了宿主MTOR抑制反应。
因此,我们假设在哺乳动物巨噬细胞中MTOR的功能下游
稳态机制感知入侵微生物增强的致病潜力
主机防御。这种机制是通过检测由毒力适应所编码的
细菌病原体(例如专业分泌系统和分泌的毒素),
经常产生病原体特异性签名。在第一个目标中,我们将确定
当主机抑制途径为
灭活。在第二个目标中,我们将使用生化和遗传学方法
确定寄主代谢调节剂如何控制军团菌的细胞内生态位。我们的
第三个目的是阐明引起mtor抑制的病原体特征是如何
生成。为此,我们将对小军团菌的细胞内小裂进行系统分析
使用各种成像方法来定义触发mTOR的早期事件
抑制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stanimir Stefanov Ivanov其他文献
Stanimir Stefanov Ivanov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stanimir Stefanov Ivanov', 18)}}的其他基金
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
中央真核代谢检查点激酶雷帕霉素 (MTOR) 调节嗜肺军团菌发病机制
- 批准号:
10092094 - 财政年份:2019
- 资助金额:
$ 36.5万 - 项目类别:
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
中央真核代谢检查点激酶雷帕霉素 (MTOR) 调节嗜肺军团菌发病机制
- 批准号:
10553242 - 财政年份:2019
- 资助金额:
$ 36.5万 - 项目类别:
Analysis of F-box domain containing effector proteins from Legionella pneumophila
含 F-box 结构域的嗜肺军团菌效应蛋白分析
- 批准号:
7333882 - 财政年份:2008
- 资助金额:
$ 36.5万 - 项目类别:
Analysis of F-box domain containing effector proteins from Legionella pneumophila
含 F-box 结构域的嗜肺军团菌效应蛋白分析
- 批准号:
7576736 - 财政年份:2008
- 资助金额:
$ 36.5万 - 项目类别:
相似国自然基金
肺泡巨噬细胞嘌呤代谢紊乱介导重症肺炎发病的作用机制研究
- 批准号:82370010
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SIRT5-线粒体代谢轴失调介导SORT1Hi肺泡巨噬细胞METs形成在围术期急性肺损伤中的作用及机制研究
- 批准号:82371292
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于代谢重编程解析G.parasuis感染后猪肺泡巨噬细胞极化的分子机制
- 批准号:32372972
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
HO-1修饰iPSC-MSCs来源外泌体调控肺泡巨噬细胞糖代谢重编程在脓毒症急性肺损伤中的作用及机制研究
- 批准号:82372154
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Cidec通过调节肺泡巨噬细胞脂代谢抑制过敏性气道炎症的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Macrophage Immunometabolism alteration by intense beta agonist therapy.
强β激动剂治疗改变巨噬细胞免疫代谢。
- 批准号:
10472466 - 财政年份:2020
- 资助金额:
$ 36.5万 - 项目类别:
Macrophage Immunometabolism alteration by intense beta agonist therapy.
强β激动剂治疗改变巨噬细胞免疫代谢。
- 批准号:
10160953 - 财政年份:2020
- 资助金额:
$ 36.5万 - 项目类别:
Macrophage Immunometabolism alteration by intense beta agonist therapy.
强β激动剂治疗改变巨噬细胞免疫代谢。
- 批准号:
9973300 - 财政年份:2020
- 资助金额:
$ 36.5万 - 项目类别:
Macrophage Immunometabolism alteration by intense beta agonist therapy.
强β激动剂治疗改变巨噬细胞免疫代谢。
- 批准号:
10002645 - 财政年份:2019
- 资助金额:
$ 36.5万 - 项目类别:
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
中央真核代谢检查点激酶雷帕霉素 (MTOR) 调节嗜肺军团菌发病机制
- 批准号:
10092094 - 财政年份:2019
- 资助金额:
$ 36.5万 - 项目类别: